Spironolactone Tablet, Film Coated
Product Images NDC 71335-2207

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71335-2207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Spironolactone 01)

Structure (Spironolactone 01)
Chemical structure of spironolactone, showing its molecular framework with characteristic functional groups including a lactone ring and a thioester moiety.*
FDA Label Image

Figure 1 (Spironolactone 02)

Figure 1 (Spironolactone 02)
A Kaplan-Meier survival curve showing the probability of an event over 48 months. The graph compares two groups: Spironolactone (n=822) and Placebo (n=841), with the Spironolactone group having higher survival probability. Statistical significance is indicated with a log-rank p-value less than 0.001.*
FDA Label Image

Figure 2 (Spironolactone 03)

Figure 2 (Spironolactone 03)
A forest plot figure displaying hazard ratios (HR) and 95% confidence intervals (CI) for multiple subgroups comparing spironolactone and placebo effectiveness. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes presence, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use, each with corresponding sample sizes (N). The plot visually indicates whether spironolactone or placebo is favored per subgroup.*
FDA Label Image

Label (Lbl713352207)

Label (Lbl713352207)
SPIRONOLACTONE 50 mg film-coated tablets label shows a package of 100 tablets with NDC 71335-2207-1. The label states the active ingredient is Spironolactone USP 50 mg. It includes storage instructions, a tablet debossed code MP 542, and manufacturer details Frontida BioPharm, with relabeler Bryant Ranch Prepack.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.